2012 Q4 Form 10-K Financial Statement

#000144530513000644 Filed on March 18, 2013

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2012 Q2
Revenue $1.090M $869.0K $627.0K
YoY Change 69.25% 32.87% -20.23%
Cost Of Revenue $300.0K -$217.2K -$128.5K
YoY Change
Gross Profit $790.0K $1.086M $755.5K
YoY Change 23.44% 67.11% -4.37%
Gross Profit Margin 72.48% 124.99% 120.49%
Selling, General & Admin $2.650M $2.590M $3.360M
YoY Change -2.21% 0.78% 26.32%
% of Gross Profit 335.44% 238.45% 444.75%
Research & Development $2.370M -$2.606M -$2.911M
YoY Change -17.13% -203.0% -203.23%
% of Gross Profit 300.0% -239.91% -385.34%
Depreciation & Amortization $130.0K $400.0K $540.0K
YoY Change -76.36% -29.82% -3.57%
% of Gross Profit 16.46% 36.83% 71.48%
Operating Expenses $5.020M -$2.606M -$2.911M
YoY Change -9.87% -151.2% -153.03%
Operating Profit -$4.230M -$4.541M -$5.771M
YoY Change -14.2% 2.28% 22.8%
Interest Expense -$1.210M -$1.191M -$1.152M
YoY Change 10.0% 9.27% 9.67%
% of Operating Profit
Other Income/Expense, Net $0.00 $2.880K $0.00
YoY Change -100.0%
Pretax Income -$5.440M -$5.730M -$6.920M
YoY Change -9.63% 3.62% 20.14%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.441M -$5.729M -$6.923M
YoY Change -9.62% 3.52% 20.21%
Net Earnings / Revenue -499.17% -659.26% -1104.15%
Basic Earnings Per Share -$0.23 -$0.24 -$0.31
Diluted Earnings Per Share -$0.23 -$0.24 -$0.31
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.50M $24.80M $25.50M
YoY Change 100.93% 68.71% 112.5%
Cash & Equivalents $21.47M $24.76M $25.46M
Short-Term Investments
Other Short-Term Assets $32.16K $600.0K $900.0K
YoY Change -95.4% -53.85% -25.0%
Inventory $16.02K $0.00 $0.00
Prepaid Expenses $545.9K
Receivables $552.3K $400.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $22.61M $25.80M $26.50M
YoY Change 88.39% 61.25% 99.25%
LONG-TERM ASSETS
Property, Plant & Equipment $2.606M $2.700M $3.100M
YoY Change -36.99% -42.55% -39.22%
Goodwill $2.572M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.299M $1.100M $1.100M
YoY Change 18.71% 0.0% -15.38%
Total Long-Term Assets $6.478M $6.400M $6.800M
YoY Change -16.99% -23.81% -23.6%
TOTAL ASSETS
Total Short-Term Assets $22.61M $25.80M $26.50M
Total Long-Term Assets $6.478M $6.400M $6.800M
Total Assets $29.09M $32.20M $33.30M
YoY Change 46.88% 31.97% 50.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $634.8K $500.0K $600.0K
YoY Change -21.43% 0.0% 100.0%
Accrued Expenses $2.168M $2.800M $1.800M
YoY Change 25.32% -9.68% -18.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $204.1K $200.0K $200.0K
YoY Change 3.24% 0.0% 100.0%
Total Short-Term Liabilities $4.813M $4.800M $4.600M
YoY Change 1.25% -18.64% -4.17%
LONG-TERM LIABILITIES
Long-Term Debt $35.70M $35.30M $35.00M
YoY Change 9.17% 14.24% 14.75%
Other Long-Term Liabilities $1.365M $5.300M $5.000M
YoY Change 26.4% 43.24% 21.95%
Total Long-Term Liabilities $1.365M $40.60M $40.00M
YoY Change 26.4% 17.34% 15.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.813M $4.800M $4.600M
Total Long-Term Liabilities $1.365M $40.60M $40.00M
Total Liabilities $6.178M $51.00M $50.20M
YoY Change 5.91% 26.24% 27.41%
SHAREHOLDERS EQUITY
Retained Earnings -$619.0M
YoY Change 1.86%
Common Stock $246.5K
YoY Change 14.44%
Preferred Stock
YoY Change
Treasury Stock (at cost) $324.8K $324.8K $324.8K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 43.49K shares
Shareholders Equity -$17.60M -$18.70M -$16.90M
YoY Change
Total Liabilities & Shareholders Equity $29.09M $32.20M $33.30M
YoY Change 46.88% 31.97% 50.0%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2012 Q2
OPERATING ACTIVITIES
Net Income -$5.441M -$5.729M -$6.923M
YoY Change -9.62% 3.52% 20.21%
Depreciation, Depletion And Amortization $130.0K $400.0K $540.0K
YoY Change -76.36% -29.82% -3.57%
Cash From Operating Activities -$3.280M -$3.640M -$3.340M
YoY Change -21.53% 7.06% -17.12%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K -$70.00K
YoY Change 600.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 -$30.00K -$70.00K
YoY Change -101.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K 2.970M 4.280M
YoY Change -105.26% -51.39% 943.9%
NET CHANGE
Cash From Operating Activities -3.280M -3.640M -3.340M
Cash From Investing Activities 0.000 -30.00K -70.00K
Cash From Financing Activities -10.00K 2.970M 4.280M
Net Change In Cash -3.290M -700.0K 870.0K
YoY Change -17.54% -125.83% -36.96%
FREE CASH FLOW
Cash From Operating Activities -$3.280M -$3.640M -$3.340M
Capital Expenditures $0.00 -$30.00K -$70.00K
Free Cash Flow -$3.280M -$3.610M -$3.270M
YoY Change -21.53% 6.18% -18.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
807928 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
634752 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
552334 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2168338 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1730290 USD
CY2011Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
892000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
919000 USD
CY2012Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
592000 USD
CY2011Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
184000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26081778 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27404751 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
581392602 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
595917080 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2813304 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3335066 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4074814 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
363000 USD
CY2010 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
690000 USD
CY2012 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2010 us-gaap Asset Impairment Charges
AssetImpairmentCharges
629382 USD
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
694441 shares
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
778982 shares
CY2012Q4 us-gaap Assets
Assets
29092623 USD
CY2011Q4 us-gaap Assets
Assets
19807530 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
12004079 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
22614688 USD
CY2012 us-gaap Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition
AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition
11000 USD
CY2011 us-gaap Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition
AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition
37000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21468269 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10747951 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19781976 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20066817 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10720318 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9034025 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-284841 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1303000 USD
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21535037 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24645112 shares
CY2007Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
270562 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
215350 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
246451 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
671972 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
CY2010 us-gaap Cost Of Goods Sold
CostOfGoodsSold
122946 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
39200000 USD
CY2012 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
33479 shares
CY2011Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
405000 USD
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
0 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
5200000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1527883 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1542395 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2078651 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4800776 USD
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
202021000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
204319000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1949000 USD
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
175965000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
178966000 USD
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
13510000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12606000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12546000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12747000 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
200072000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
203016000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1303000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1949000 USD
CY2010 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
42000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
48000 USD
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0 USD
CY2012 us-gaap Depreciation
Depreciation
1600000 USD
CY2011 us-gaap Depreciation
Depreciation
2200000 USD
CY2010 us-gaap Depreciation
Depreciation
2600000 USD
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3437767 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1622736 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2252412 USD
CY2012 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update No.&#160;2011-05, Comprehensive Income (&#8220;ASU 2011-05&#8221;) which increases the prominence of other comprehensive income in financial statements.&#160;Under this standard, the components of net income and other comprehensive income must be presented in either one or two consecutive financial statements.&#160;The standard eliminates the option to present other comprehensive income in the statement of changes in equity.&#160;ASU 2011-05 was effective for fiscal years beginning after December&#160;15, 2011 and interim and annual periods thereafter.&#160; Adoption of this standard did not have a material effect on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2013, the FASB issued Accounting Standard Update No. 2013-02, Reporting of Amounts Reclassified out of Accumulated other Comprehensive Income, ("ASU 2013-02"). ASU 2013-02 requires entities to disclose items reclassified out of accumulated Other Comprehensive Income ("AOCI") and into net income in their entirety, the effect of the reclassification on each affected net income line item, and, for AOCI reclassification items that are not reclassified in their entirety into net income, a cross reference to other required U.S. GAAP disclosures. This consolidated standard is effective for annual periods beginning after December 31, 2012 and interim periods within those years. The application of this standard will not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2011, the FASB issued Accounting Standard Update No. 2011-08, Intangibles&#8212;Goodwill and Other (Topic 350): Testing Goodwill for Impairment (the revised standard) ("ASU 2011-08"). ASU 2011-08 simplifies how entities test goodwill for impairment. This amended guidance permits companies to first assess assess qualitative factors to determine whether it is necessary to perform the two-step goodwill impairment test. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required. Otherwise, no further testing is required. The revised standard was effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Adoption of this provisions of this guidance did not have a material impact on our consolidated results of operations, cash flows, and financial position. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2012, the FASB issued Accounting Standard Update No.&#160;2012-02, &#8220;Intangibles-Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment&#8221; (&#8220;ASU 2012-02&#8221;). ASU 2012-02 simplifies the guidance for testing the impairment of indefinite-lived intangible assets other than goodwill. The guidance allows an entity the option to first assess qualitative factors to determine whether it is necessary to perform the quantitative impairment test. An entity electing to perform a qualitative assessment is no longer required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on a qualitative assessment, that it is &#8220;more likely than not&#8221; that the asset is impaired. This guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. We adopted this standard in the fourth quarter of 2012. The adoption of ASU 2012-02 did not have a material effect on our consolidated financial statements.</font></div></div>
CY2011 us-gaap Dividends Preferred Stock
DividendsPreferredStock
790500 USD
CY2010 us-gaap Dividends Preferred Stock
DividendsPreferredStock
790500 USD
CY2012 us-gaap Dividends Preferred Stock
DividendsPreferredStock
791735 USD
CY2010 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
790500 USD
CY2011 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
790500 USD
CY2012 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
395250 USD
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.41
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2012 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition
2.2
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000 USD
CY2010 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
45000 USD
CY2010 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-161188 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-37447 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11026 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2010 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2761426 USD
CY2011 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
0 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
2192000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11465092 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10820187 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12111507 USD
CY2012Q4 us-gaap Goodwill
Goodwill
2572203 USD
CY2011Q4 us-gaap Goodwill
Goodwill
2572203 USD
CY2011 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2010 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2012 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2944000 USD
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5033000 USD
CY2010 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2760000 USD
CY2010 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7451000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3850000 USD
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7912000 USD
CY2010 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
0 USD
CY2010 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
795000 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
640000 USD
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-169000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
26000 USD
CY2010 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
67000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
59000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-581000 USD
CY2010 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-534000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-1182000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-181848 USD
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-198116 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
105667 USD
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
552334 USD
CY2010 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
674101 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2707613 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1531495 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4050 USD
CY2010 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-297603 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6360 USD
CY2012 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
542349 USD
CY2011 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-269713 USD
CY2010 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-246879 USD
CY2011 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
591504 USD
CY2010 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
152221 USD
CY2012 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-747982 USD
CY2010 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-47216 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9637 USD
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-168474 USD
CY2010 us-gaap Interest Expense
InterestExpense
4871446 USD
CY2011 us-gaap Interest Expense
InterestExpense
4210097 USD
CY2012 us-gaap Interest Expense
InterestExpense
4718037 USD
CY2012 us-gaap Interest Paid
InterestPaid
1573554 USD
CY2010 us-gaap Interest Paid
InterestPaid
1122473 USD
CY2011 us-gaap Interest Paid
InterestPaid
12458 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
20072 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
16022 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
18787 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
23336 USD
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
37560 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000 USD
CY2010 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2600000 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000 USD
CY2012Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29092623 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19807530 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4753639 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4812988 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
197684 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
204088 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7244348 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4543095 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9811158 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103442 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29462 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9930099 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14758035 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1012602 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16248911 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-21906303 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-11324771 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-23276175 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-5963000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-5759000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-5534000 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-6020000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
6768000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5729000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-6923000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-5441000 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24066675 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12116506 USD
CY2010 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22696803 USD
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6161000 USD
CY2011Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6217000 USD
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5957000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5732000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6570000 USD
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5639000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5927000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7121000 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1941 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
110473 USD
CY2010 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4680120 USD
CY2011 us-gaap Notes Assumed1
NotesAssumed1
171640 USD
CY2010 us-gaap Notes Assumed1
NotesAssumed1
0 USD
CY2012 us-gaap Notes Assumed1
NotesAssumed1
0 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-19086806 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-21752537 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-6740543 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15762000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1336000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1548000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1490000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1448000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1407000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8533000 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
602000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
366000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32156 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
699786 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1094549 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1299304 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
475342 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
277927 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1365357 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1080201 USD
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
3141475 USD
CY2011 us-gaap Other Noncash Expense
OtherNoncashExpense
4167849 USD
CY2010 us-gaap Other Noncash Expense
OtherNoncashExpense
4053272 USD
CY2011Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0 USD
CY2012Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
137000 USD
CY2012 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
592875 USD
CY2011 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
790500 USD
CY2010 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
790500 USD
CY2012 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2010 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
29989763 USD
CY2011 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4998799 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103442 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54547 USD
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
130437 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
536270 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
545907 USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8600000 USD
CY2011Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6300000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1200000 USD
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000 USD
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000 USD
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
52193 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
81098 USD
CY2010 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
48603 USD
CY2010 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
11525236 USD
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
7980375 USD
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10464203 USD
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5000000 USD
CY2010 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
40000000 USD
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2010 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6240963 USD
CY2011 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2012 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-100000 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23884 USD
CY2010 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50299 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26381 USD
CY2010 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
719 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1438 USD
CY2012 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
79000 USD
CY2010 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
49000 USD
CY2011 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
83000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30011000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30218000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2606428 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4136699 USD
CY2012 us-gaap Property Plant And Equipment Useful Life Maximum
PropertyPlantAndEquipmentUsefulLifeMaximum
10 Y
CY2012 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
399000 USD
CY2011 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
541000 USD
CY2013 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
286000 USD
CY2010 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
1100000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11022391 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10564195 USD
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12877695 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-619019367 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-607694596 USD
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2010 us-gaap Revenue From Grants
RevenueFromGrants
424720 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2010 us-gaap Revenues
Revenues
3359611 USD
CY2012 us-gaap Revenues
Revenues
15960716 USD
CY2011 us-gaap Revenues
Revenues
2755772 USD
CY2011Q4 us-gaap Revenues
Revenues
644000 USD
CY2011Q1 us-gaap Revenues
Revenues
672000 USD
CY2011Q3 us-gaap Revenues
Revenues
654000 USD
CY2011Q2 us-gaap Revenues
Revenues
786000 USD
CY2012Q1 us-gaap Revenues
Revenues
13375000 USD
CY2012Q4 us-gaap Revenues
Revenues
1090000 USD
CY2012Q3 us-gaap Revenues
Revenues
869000 USD
CY2012Q2 us-gaap Revenues
Revenues
627000 USD
CY2008Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.00
CY2008Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.68
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2010 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
52500 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1489821 USD
CY2011 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
0 USD
CY2010 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
0 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
6.6 Y
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12000 USD
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
204000 USD
CY2012Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
35679232 USD
CY2011Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
32637757 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
3151537 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
4303961 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
2646767 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
7170 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
6.23
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
644557 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.42
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
249968 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
135791 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.38
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.85
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
523210 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.31
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 Y
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 Y
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 Y
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.03
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.96
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.04
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.87
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
60196 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
18.02
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10007 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.65
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1011750 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.33
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.66
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.61
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
305834 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1814161 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.38
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1556564 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
8.54
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm
7.7 Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
297241 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2651507 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.14
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
180982 USD
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
7.7 Y
CY2011Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2287581 shares
CY2011 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
6 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6825 shares
CY2010 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
48603 USD
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
81098 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
52193 USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8645730 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7503375 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10464203 USD
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10361920 USD
CY2011 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2012 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
719 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1438 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26381 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-20830965 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-17600157 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-16974967 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-14707212 USD
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43490 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43490 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
324792 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
324792 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5488000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5533000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
35000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
10000 USD
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</font></div></div>
CY2011 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
0 USD
CY2012 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
0 USD
CY2010 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
1910156 USD
CY2008Q1 agen Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P9Y6M
CY2009Q3 agen Class Of Warrant Or Right Non Exercisable Term
ClassOfWarrantOrRightNonExercisableTerm
P6M
CY2008Q1 agen Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P10Y
CY2011Q4 agen Clinical Trials
ClinicalTrials
52000 USD
CY2012Q4 agen Clinical Trials
ClinicalTrials
291000 USD
CY2010 agen Clinical Trials Expense
ClinicalTrialsExpense
361000 USD
CY2012 agen Clinical Trials Expense
ClinicalTrialsExpense
654000 USD
CY2011 agen Clinical Trials Expense
ClinicalTrialsExpense
623000 USD
CY2012 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
0 USD
CY2011 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
5580124 USD
CY2010 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
0 USD
CY2012Q4 agen Cumulative Payments For Clinical Trials
CumulativePaymentsForClinicalTrials
47400000 USD
CY2012 agen Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
48000 USD
CY2010 agen Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
42000 USD
CY2012 agen Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2011 agen Effect On Additional Paid In Capital Due To Note Amendment
EffectOnAdditionalPaidInCapitalDueToNoteAmendment
-6335124 USD
CY2012Q4 agen Estimate Of Total Payments For Clinical Trials
EstimateOfTotalPaymentsForClinicalTrials
51100000 USD
CY2010 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
0 USD
CY2011 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
-28063 USD
CY2012 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
-38744 USD
CY2011 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
2829105 USD
CY2012 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
1499981 USD
CY2010 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
2615667 USD
CY2010 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-4363000 USD
CY2012 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-821000 USD
CY2011 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-1979000 USD
CY2009Q1 agen New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Debt Discount
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnDebtDiscount
1300000 USD
CY2009Q1 agen New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Derivative Liability
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnDerivativeLiability
2700000 USD
CY2011Q4 agen Noncontrolling Interest
NoncontrollingInterest
5580124 USD
CY2012Q4 agen Noncontrolling Interest
NoncontrollingInterest
5580124 USD
CY2012Q4 agen Other Ltd
OtherLTD
34427 USD
CY2011Q4 agen Other Ltd
OtherLTD
88247 USD
CY2012 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
0 USD
CY2010 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
0 USD
CY2011 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
755000 USD
CY2010 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-67224 USD
CY2011 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-78079 USD
CY2012 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-31945 USD
CY2010 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
2882391 USD
CY2012 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
14470895 USD
CY2011 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
2755772 USD
CY2012Q4 agen Share Based Compensation Arrangement By Share Based Payment Award Options Grants Liabilities Current
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsLiabilitiesCurrent
141000 USD
CY2011Q4 agen Share Based Compensation Arrangement By Share Based Payment Award Options Grants Liabilities Current
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsLiabilitiesCurrent
70000 USD
CY2011 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
330000 USD
CY2012 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
2100000 USD
CY2010 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
1600000 USD
CY2012 agen Share Based Compensation Expense
ShareBasedCompensationExpense
4304000 USD
CY2011 agen Share Based Compensation Expense
ShareBasedCompensationExpense
2647000 USD
CY2010 agen Share Based Compensation Expense
ShareBasedCompensationExpense
3152000 USD
CY2008Q2 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1166666 shares
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
833333 shares
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
730994 shares
CY2008Q1 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1451450 shares
CY2010 agen Shares Issued In Private Placements Value
SharesIssuedInPrivatePlacementsValue
2879506 USD
CY2011 agen Shares Issued In Private Placements Value
SharesIssuedInPrivatePlacementsValue
477000 USD
CY2010 agen Shares Issued To Repurchase Convertible Senior Notes Value
SharesIssuedToRepurchaseConvertibleSeniorNotesValue
10361920 USD
CY2007Q3 agen Stock Issued During Period Price Per Share
StockIssuedDuringPeriodPricePerShare
18.48
CY2010Q4 agen Subscription Agreement Terms Additional Purchase Option Exercise Period
SubscriptionAgreementTermsAdditionalPurchaseOptionExercisePeriod
P90D
CY2011 agen Terms Of Private Placement Subsequent Offering Potential Proceeds From Issuance Of Private Placement
TermsOfPrivatePlacementSubsequentOfferingPotentialProceedsFromIssuanceOfPrivatePlacement
575901 USD
CY2010 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2011 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2012 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2012 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
23628903 shares
CY2011 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
19898632 shares
CY2010 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
16108353 shares
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001098972
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25299770 shares
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q2 dei Entity Public Float
EntityPublicFloat
115800000 USD
CY2012 dei Entity Registrant Name
EntityRegistrantName
AGENUS INC
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001445305-13-000644-index-headers.html Edgar Link pending
0001445305-13-000644-index.html Edgar Link pending
0001445305-13-000644.txt Edgar Link pending
0001445305-13-000644-xbrl.zip Edgar Link pending
agen-12312012x10k.htm Edgar Link pending
agen-12312012x10k_chart.jpg Edgar Link pending
agen-20121231.xml Edgar Link completed
agen-20121231.xsd Edgar Link pending
agen-20121231_cal.xml Edgar Link unprocessable
agen-20121231_def.xml Edgar Link unprocessable
agen-20121231_lab.xml Edgar Link unprocessable
agen-20121231_pre.xml Edgar Link unprocessable
agen-exhibit102.htm Edgar Link pending
agen-exhibit1022.htm Edgar Link pending
agen-exhibit104.htm Edgar Link pending
agen-exhibit109.htm Edgar Link pending
agen-exhibit23.htm Edgar Link pending
agen-exhibit311.htm Edgar Link pending
agen-exhibit312.htm Edgar Link pending
agen-exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending